COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases

References

• Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review. J Intern Med. 2021;289(4):450–62. doi:10.1111/joim.13184.
   PubMed Web of Science ®Google Scholar
• Robinson PC, Yazdany J, Machado PM. Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 global rheumatology alliance. Curr Opin Rheumatol. 2021;33(2):111–16. doi:10.1097/BOR.0000000000000783.
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Marotto D, Caporali R, Montecucco CM, Favalli EG, Franceschini F, Fredi M, Balduzzi S, Bazzani C, Bongiovanni S, et al. Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: a multicentre retrospective study. J Autoimmun. 2021;116:102545. doi:10.1016/j.jaut.2020.102545.
   PubMed Web of Science ®Google Scholar
• Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, et al. Characteristics associated with hospitalization for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry. Ann Rheum Dis. 2020;79(7):859–66. doi:10.1136/annrheumdis-2020-217871.
   PubMed Web of Science ®Google Scholar
• Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2020;13:218946. doi:10.1136/annrheumdis-2020-218946.
   Google Scholar
• Furer V, Rondaan C, Agmon-Levin N, van Assen S, Bijl M, Kapetanovic MC, de Thurah A, Mueller-Ladner U, Paran D, Schreiber K, et al. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases. RMD Open. 2021;7(1):e001594. doi:10.1136/rmdopen-2021-001594.
   PubMed Web of Science ®Google Scholar
• Coustasse A, Kimble C, Maxik K. Letter to the editor: COVID-19 and vaccine hesitancy a challenge the United States must overcome. J Ambulatory Care Manage. 2021;44(1):71–75. doi:10.1097/JAC.0000000000000360.
   PubMed Web of Science ®Google Scholar
• MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Ten threats to global health in 2019. Geneva (Switzerland): WHO; 2012.
   Google Scholar
• D’Souza G, Dowdy D. What is herd immunity and how can we achieve it with COVID-19? Johns Hopkins Bloomberg school of public health expert insights. [accessed 2021 January 15]. https://www.jhsph.edu/covid-19/articles/achieving-herd-immunity-with-covid19.html.
   Google Scholar
• Lin C, Tu P, Beitsch LM. Confidence and receptivity for COVID-19 vaccines: a rapid systematic review. Vaccines (Basel). 2020;9(1):16. doi:10.3390/vaccines9010016.
   PubMed Web of Science ®Google Scholar
• Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson H, Teerawattananon Y, Jit M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023–34. doi:10.1016/S0140-6736(21)00306-8.
   PubMed Web of Science ®Google Scholar
• Thigpen CL, Funk C. Most Americans expect a COVID-19 vaccine within a year; 72% say they would get vaccinated. [accessed 10 August 2020]. https://www.pewresearch.org/fact-tank/2020/05/21/mostamericans-expect-a-covid-19-vaccine-within-a-year-72-say-theywould-get-vaccinated/.
   Google Scholar
• King’s College London. Who’s least likely to say they’ll get a COVID-19 vaccine? [accessed 2021 February 6]. https://www.kcl.ac.uk/news/whos-least-likely-to-say-they%26#x2019;ll-get-a-covid-19-vaccine.
   Google Scholar
• Peretti-Watel P, Seror V, Cortaredona S, Launay O, Raude J, Verger P, Fressard L, Beck F, Legleye S, L’Haridon O; COCONEL Group. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20(7):769–70. doi:10.1016/S1473-3099(20)30426-6.
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Thomas K, Shah MD, Vizueta N, Cui Y, Vangala S, Kapteyn A. National trends in the US public’s likelihood of getting a COVID-19 vaccine - April 1 to December 8, 2020. JAMA. 2021;325(4):396–98. doi:10.1001/jama.2020.26419.
   Web of Science ®Google Scholar
• Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–28. doi:10.1038/s41591-020-1124-9.
   PubMed Web of Science ®Google Scholar
• Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–21. doi:10.1016/S2468-2667(21)00012-8.
   PubMed Web of Science ®Google Scholar
• Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, Jenner L, Petit A, Lewandowsky S, Vanderslott S, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2020;11:1–15. doi:10.1017/S0033291720005188.
   Google Scholar
• Caserotti M, Girardi P, Rubaltelli E, Tasso A, Lotto L, Gavaruzzi T. Associations of COVID-19 risk perception with vaccine hesitancy over time for Italian residents. Soc Sci Med. 2021;272:113688. doi:10.1016/j.socscimed.2021.113688.
   PubMed Web of Science ®Google Scholar
• Cines DB, Bussel JB. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. N Engl J Med. 2021;384(23):2254–56. doi:10.1056/NEJMe2106315.
   PubMed Web of Science ®Google Scholar
• Boekel L, Hooijberg F, van Kempen ZLE, Vogelzang EH, Sw T, Killestein J, Nurmohamed MT, Boers M, Kuijpers TW, van Ham SM, et al. Perspective of patients with autoimmune diseases on COVID-19 vaccination. Lancet. 2021;3:e241–3. doi:10.1016/S2665-9913(21)00037-0.
   Web of Science ®Google Scholar
• Felten R, Dubois M, Ugarte-Gil MF, Chaudier A, Kawka L, Bergier H, Costecalde C, Pijnenburg L, Fort J, Chatelus E, et al. Vaccination against COVID-19: expectations and concerns of patients with autoimmune and rheumatic diseases. Lancet Rheumatol. 2021;3(4):e243–5. doi:10.1016/S2665-9913(21)00039-4.
   PubMedGoogle Scholar
• Priori R, Pellegrino G, Colafrancesco S, Alessandri C, Ceccarelli F, Di Franco M, Riccieri V, Scrivo R, Sili Scavalli A, Spinelli FR, et al. SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists. Ann Rheum Dis. 2021;80(7):953–54. doi:10.1136/annrheumdis-2021-220059.
   PubMed Web of Science ®Google Scholar
• Yurttas B, Poyraz BC, Sut N, Ozdede A, Oztas M, Uğurlu S, Tabak F, Hamuryudan V, Seyahi E. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web based survey. Rheumatol Int. 2021;41(6):1105–14. doi:10.1007/s00296-021-04841-3.
   PubMed Web of Science ®Google Scholar
• Smerilli G, Cipolletta E, Moscioni E, Francioso F, Risa AM, Maccarrone V, Zompa D, Di Matteo A, Di Carlo M, De Angelis R, et al. Correspondence on ‘SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists.’ Ann Rheum Dis. 2021;80(10):e168–e168. doi:10.1136/annrheumdis-2021-220586.
   PubMed Web of Science ®Google Scholar
• Gaur P, Agrawat H, Shukla A. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview based survey. Rheumatol Int. 2021;41(9):1601–05. doi:10.1007/s00296-021-04938-9.
   PubMed Web of Science ®Google Scholar
• Boucher VG, Pelaez S, Gemme C, Labbe S, Lavoie KL. Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: a scoping literature review. Clin Rheumatol. 2021;40(2):477–89. doi:10.1007/s10067-020-05059-7.
   PubMed Web of Science ®Google Scholar
• Figueroa-Parra G, Esquivel-Valerio JA, Santoyo-Fexas L, Moreno-Salinas A, Gamboa-Alonso CM, De Leon-Ibarra AL, Galarza-Delgado DA. Knowledge and attitudes about influenza vaccination in rheumatic diseases patients. Hum Vaccin Immunother. 2021;17(5):1420–25. doi:10.1080/21645515.2020.1816108.
   PubMed Web of Science ®Google Scholar
• Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, et al. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 global rheumatology alliance vaccine survey. RMD Open. 2021 Sep;7(3):e001814. doi:10.1136/rmdopen-2021-001814.
   PubMed Web of Science ®Google Scholar
• Vergera P, Dubéc E. Restoring confidence in vaccines in the COVID-19 era. Expert Rev Vaccines. 2020;19(11):991–93. doi:10.1080/14760584.2020.1825945.
   PubMed Web of Science ®Google Scholar
• ACR COVID-19 vaccine guidance recommends vaccination, addresses immunosuppressant drugs & patient concerns. [accessed 2021 August 19]. https://www.rheumatology.org/About-us/Newsroom/Press-releases/ID/1138.
   Google Scholar
• EULAR. EULAR view-points on SARS-CoV-2 vaccination in patients with RMDs; 2020 December. Consulted 2021 October 5 in https://www.eular.org/eular_sars_cov_2_vaccination_rmd_patients.cfm.
   Google Scholar
• Hasseli R, Pfeil A, Krause A, Schulze-Koops H, Müller-Ladner U, Specker C, Hoyer B, Lorenz H-M, Regierer A, Richter J; COVID-19 Task Force of the German Society for Rheumatology (DGRh). A survey to evaluate knowledge, perceptions and attitudes toward COVID-19 vaccinations among rheumatologists in Germany. Rheumatol Int. 2021 Nov;41(11):1949–56. doi:10.1007/s00296-021-04986-1.
   PubMed Web of Science ®Google Scholar
• Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P. Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8(2):94–104. doi:10.1111/j.1524-4733.2005.04054.x.
   PubMed Web of Science ®Google Scholar
• Domek GJ, O’Leary ST, Bull S, Bronsert M, Contreras-Roldan IL, Bolaños-Ventura GA, Kempe A, Asturias EJ. Measuring vaccine hesitancy: field testing the WHO SAGE working group on vaccine hesitancy survey tool in Guatemala. Vaccine. 2018;36(35):5273–81. doi:10.1016/j.vaccine.2018.07.046.
   PubMed Web of Science ®Google Scholar
• Vacunarse. Su vacunación contra el COVID-19. [accessed 2021 August 19]. https://espanol.cdc.gov/coronavirus/2019-ncov/vaccines/your-vaccination.html.
   Google Scholar
• Guaracha-Basáñez GA, Contreras-Yáñez I, Hernández-Molina G, González-Marín A, Pacheco-Santiago LD, Valverde-Hernández SS, Peláez-Ballestas I, Pascual-Ramos V. Clinical and bioethical implications of health care interruption during the covid-19 pandemic: a cross-sectional study in outpatients with rheumatic diseases. PLoS One. 2021;16(7):e0253718. doi:10.1371/journal.pone.0253718.
   PubMed Web of Science ®Google Scholar
• England BR, Sayles H, Mikuls TR, Johson DS, Michaud K. Validation of the rheumatic disease comorbidity index. Arthritis Care Res (Hoboken). 2015;67(6):865–72. doi:10.1002/acr.22456.
   PubMed Web of Science ®Google Scholar
• Choi BC, Pak AW. A catalog of biases in questionnaires. Prev Chronic Dis. 2005;2:A13.
   PubMedGoogle Scholar
• Steiner DL, Norman GR, and Cairney J. Health measurement scales. A practical guide to their development and use. 3th ed. New York/EUA: Oxford University; 2003.
   Google Scholar
• Cohen J. Statistical power analysis for the behavioural sciences. New York/EUA: Academic Press; 1977.
   Google Scholar
• Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol. 2000;53(5):459–68. doi:10.1016/s0895-4356(99)00206-1.
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Statistics notes: Cronbach's alpha. BMJ. 1997;314(7080):572. doi:10.1136/bmj.314.7080.572.
   PubMed Web of Science ®Google Scholar
• Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63. doi:10.1016/j.jcm.2016.02.012.
   PubMed Web of Science ®Google Scholar
• Machingaidze S, Wiysonge CS. Understanding COVID-19 vaccine hesitancy. A new study unpacks the complexities of COVID-19 vaccine hesitancy. Nat Med. 2021;27(8):1338–39. doi:10.1038/s41591-021-01459-7.
   PubMed Web of Science ®Google Scholar
• Lohr KN, Zebrack BJ. Using patient-reported outcomes in clinical practice: challenges and opportunities. Qual Life Res. 2009;18(1):99–107. doi:10.1007/s11136-008-9413-7.
   PubMed Web of Science ®Google Scholar
• Pett MA, Lackey NR, and Sullivan JJ. Making sense of factor analysis: the use of factor analysis for instrument development in health care research. California/EUA: Sage Publications Inc; 2003.
   Google Scholar
• Campochiaro C, Trignani G, Tomelleri A, Cascinu S, Dagna L; COVID-19 Vaccine Study Group. Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey. Ann Rheum Dis. 2021:annrheumdis-2020-219811. doi:10.1136/annrheumdis-2020-219811.
   Web of Science ®Google Scholar
• Bugatti S, Balduzzi S, De Stefano L, Manzo A, Xoxi B, Bogliolo L, Monti S, Delvino P, Montecucco C. Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs.’ Ann Rheum Dis. 2021:annrheumdis-2021-220541. doi:10.1136/annrheumdis-2021-220862.
   Web of Science ®Google Scholar
• Ko T, Dendle C, Woolley I, Morand E, Antony A. SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study. Hum Vaccin Immunother. 2021:1–9. doi:10.1080/21645515.2021.1958611.
   Web of Science ®Google Scholar
• Gaur PS, Zimba O, Agarwal V, Gupta L. Reporting survey based studies—a primer for authors. J Korean Med Sci. 2020;35(45):e398. doi:10.3346/jkms.2020.35.e398.
   PubMed Web of Science ®Google Scholar
• Felten R, Dubois M, Ugarte-Gil MF, Chaudier A, Kawka L, Bergier H, Costecalde C, Pijnenburg L, Fort J, Chatelus E, et al. Cluster analysis reveals 3 main patterns of behavior towards SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases. Rheumatology (Oxford). 2021:keab432. doi:10.1093/rheumatology/keab432.
   PubMedGoogle Scholar
• Figueroa-Parra G, Esquivel-Valerio JA, Santoyo-Fexas L, Moreno-Salinas A, Gamboa-Alonso CM, De Leon-Ibarra AL, Galarza-Delgado DA. Knowledge and attitudes about influenza vaccination in rheumatic diseases patients. Hum Vaccin Immunother. 2021;17(5):1420–25. doi:10.1080/21645515.2020.1816108.
   PubMed Web of Science ®Google Scholar
• McEachan R, Conner M, Taylor N, Lawton R. Prospective prediction of health-related behaviours with the theory of planned behaviour: a meta-analysis. Health Psychol. 2011;5:97–144. doi:10.1080/17437199.2010.521684.
   Web of Science ®Google Scholar
• Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94. doi:10.1038/s41591-021-01454-y.
   PubMed Web of Science ®Google Scholar